Arden Trust CO Eli Lilly & CO Transaction History

Arden Trust CO

$683 Million
Q2 2024

A detailed history of Arden Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Arden Trust CO holds 3,886 shares of LLY stock, worth $2.84 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

3,886

Previous 4,175 6.92%

Holding current value

$2.84 Million

Previous $3.25 Million 8.35%

% of portfolio

0.52%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$724.87 - $909.04 $209,487 - $262,712	-289 Reduced 6.92%	3,886 $3.52 Million
Q1 2024 Apr 03, 2024	SELL	$592.2 - $792.28 $64,549 - $86,358	-109 Reduced 2.54%	4,175 $3.25 Million
Q4 2023 Jan 04, 2024	SELL	$525.19 - $619.13 $193,795 - $228,458	-369 Reduced 7.93%	4,284 $2.5 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $15,214 - $20,975	35 Added 0.76%	4,653 $2.5 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $31,917 - $42,677	-91 Reduced 1.93%	4,618 $2.17 Million
Q1 2023 Apr 14, 2023	SELL	$310.63 - $364.82 $104,371 - $122,579	-336 Reduced 6.66%	4,709 $1.62 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $100,002 - $116,522	-311 Reduced 5.81%	5,045 $0
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $370,303 - $421,999	-1,249 Reduced 18.91%	5,356 $1.73 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $252,250 - $296,179	-905 Reduced 12.05%	6,605 $2.14 Million
Q1 2022 Apr 11, 2022	SELL	$234.69 - $291.66 $345,463 - $429,323	-1,472 Reduced 16.39%	7,510 $2.15 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $276,565 - $343,219	-1,230 Reduced 12.04%	8,982 $2.48 Million
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $317,996 - $391,338	-1,435 Reduced 12.32%	10,212 $2.36 Million
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $388,001 - $501,877	-2,149 Reduced 15.58%	11,647 $2.67 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $73,944 - $95,724	-450 Reduced 3.16%	13,796 $2.58 Million
Q3 2020 Oct 15, 2020	SELL	$146.22 - $169.13 $14,622 - $16,913	-100 Reduced 0.7%	14,246 $2.11 Million
Q2 2020 Jul 09, 2020	SELL	$136.42 - $164.18 $67,527 - $81,269	-495 Reduced 3.34%	14,346 $2.36 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $321,196 - $397,550	-2,698 Reduced 15.38%	14,841 $2.06 Million
Q4 2019 Jan 17, 2020	BUY	$106.92 - $132.43 $170,965 - $211,755	1,599 Added 10.03%	17,539 $2.31 Million
Q3 2019 Oct 09, 2019	SELL	$106.79 - $116.16 $11,426 - $12,429	-107 Reduced 0.67%	15,940 $1.78 Million
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $1.78 Million - $2.08 Million	16,047 New	16,047 $1.78 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.

Account